Reversal of cognitive impairment by heptyl physostigmine, a long-lasting cholinesterase inhibitor, in primates
- 29 February 1992
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 107 (2) , 246-249
- https://doi.org/10.1016/0022-510x(92)90296-w
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Kinetics of cholinesterase inhibition by eptastigmine in manEuropean Journal of Clinical Pharmacology, 1991
- Direct comparison of cognitive facilitation by physostigmine and tetrahydroaminoacridine in two primate modelsNeurobiology of Aging, 1990
- Mechanisms of cholinesterase inhibition in senile dementia of the alzheimer type: Clinical, pharmacological, and therapeutic aspectsDrug Development Research, 1988
- A long-lasting cholinesterase inhibitor affecting neural and behavioral processesPharmacology Biochemistry and Behavior, 1987
- Acute and chronic effects of oral physostigmine and lecithin in Alzheimer's diseaseProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1986
- The Cholinergic Hypothesis of Geriatric Memory DysfunctionScience, 1982
- Physostigmine and Arecoline: Effects of Intravenous Infusions in Alzheimer Presenile DementiaThe British Journal of Psychiatry, 1981
- Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.BMJ, 1978
- The Cholinergic Synapse and the Site of MemoryScience, 1971
- A new and rapid colorimetric determination of acetylcholinesterase activityBiochemical Pharmacology, 1961